Skip to Content
Merck
CN

C1660

Cibacron Blue 3GA Agarose

Type 3000-CL-L, lyophilized powder

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

UNSPSC Code:
13111000
MDL number:
MFCD00043102

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

VZPXDCIISFTYOM-UHFFFAOYSA-K

InChI

1S/C29H20ClN7O11S3.3Na/c30-27-35-28(33-13-4-3-5-15(10-13)49(40,41)42)37-29(36-27)34-18-9-8-14(11-20(18)50(43,44)45)32-19-12-21(51(46,47)48)24(31)23-22(19)25(38)16-6-1-2-7-17(16)26(23)39;;;/h1-12,32H,31H2,(H,40,41,42)(H,43,44,45)(H,46,47,48)(H2,33,34,35,36,37);;;/q;3*+1/p-3

SMILES string

[Na+].[Na+].[Na+].Nc1c(cc(Nc2ccc(Nc3nc(Cl)nc(Nc4cccc(c4)S([O-])(=O)=O)n3)c(c2)S([O-])(=O)=O)c5C(=O)c6ccccc6C(=O)c15)S([O-])(=O)=O

type

Type 3000-CL-L

form

lyophilized powder

extent of labeling

2-5 μmol per mL

capacity

10-20 mg/mL binding capacity (bovine serum albumin)

storage temp.

2-8°C

Looking for similar products? Visit Product Comparison Guide

Physical form

Stabilized with lactose

Preparation Note

Swelling: 1 g swells to approx. 5 ml

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
061K7009
028F9605
010K7047
083K7059
060K7038

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Younis Baqi et al.
Journal of medicinal chemistry, 53(5), 2076-2086 (2010-02-12)
ecto-5'-Nucleotidase (eN, CD73) plays a major role in controlling extracellular adenosine levels. eN inhibitors have potential as novel drugs, for example, for the treatment of cancer. In the present study, we synthesized and investigated a series of 55 anthraquinone derivatives
Christa E Müller et al.
Bioorganic & medicinal chemistry letters, 16(23), 5943-5947 (2006-09-26)
Polyoxotungstates were identified as potent inhibitors of NTPDases1, 2, and 3. The most potent compound was K(6)H(2)[TiW(11)CoO(40)], exhibiting K(i) values of 0.140 microM (NTPDase1), 0.910 microM (NTPDase2), and 0.563 microM (NTPDase3). One of the compounds, (NH(4))(18)[NaSb(9)W(21)O(86)], was selective for NTPDases2
Andreas Brunschweiger et al.
Journal of medicinal chemistry, 51(15), 4518-4528 (2008-07-18)
Ecto-nucleoside triphosphate diphosphohydrolases (E-NTPDases, subtypes 1, 2, 3, 8 of NTPDases) dephosphorylate nucleoside tri- and diphosphates to the corresponding di- and monophosphates. In the present study we synthesized adenine and uracil nucleotide mimetics, in which the phosphate residues were replaced
Stefanie Weyler et al.
Bioorganic & medicinal chemistry letters, 18(1), 223-227 (2007-11-17)
A library of anilinoanthraquinone derivatives was synthesized by parallel Ullmann coupling reaction of bromaminic acid with aniline derivatives in solution using a compact parallel synthesizer. The products were purified by HPLC and evaluated as antagonists at mouse and human P2Y2
Petra Hillmann et al.
Journal of medicinal chemistry, 52(9), 2762-2775 (2009-05-08)
The P2Y(2) receptor, which is activated by UTP, ATP, and dinucleotides, was studied as a prototypical nucleotide-activated GPCR. A combination of receptor mutagenesis, determination of its effects on potency and efficacy of agonists and antagonists, homology modeling, and chemical experiments
View All Related Papers

Related Content

Product Information Sheet - C1660

Product Information Sheet

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service